期刊文献+

CALR基因对细胞生长和凋亡的调控 被引量:1

Regulation of CALR Gene on Cell Growth and Apoptosis
原文传递
导出
摘要 本研究探讨了CALR基因对细胞生长和凋亡的影响,以MDS患者的肿瘤细胞为研究对象,构建CALR-RNAi慢病毒载体,观察其对SKM-1细胞生长和凋亡的影响。结果证实,MDS患者CALR基因表达较对照组明显降低(p<0.05)。成功构建的3种CALR-RNAi慢病毒载体中,CALR-RNAi(3)慢病毒载体敲除效率最高,转染SKM-1后可促进细胞生长、抑制细胞凋亡(p<0.05),同时CALR-RNAi(3)组的G0/G1期细胞减少,S期细胞增多。CALR基因在MDS的发病及发展中扮演着抑癌基因的角色,其突变及缺失是患者发病的主要原因,关于本基因序列的深入研究对于MDS的临床治疗有重大意义。 We studied the influence of CALR gene on cell growth and apoptosis.We selected tumor cells in MDS patients as the research object,constructed RNAi lentiviral vector targeting CALR gene in SKM-1 to investigate the effect of CLAR-RNAi on proliferation and apoptosis of MDS cells.The results showed that CALR gene expression was significantly decreased in MDS patients when compared with control groups(p〈0.05).Three kinds of CALR-RNAi-expressing lentiviral vectors were successfully constructed,and the CALR-RNAi(3) lentiviral vector was the most effective vector for interfering the expression of CALR gene.CALR-RNAi(3) could promote cell growth and inhibit apoptosis in SKM-1 cells(p〈0.05).The percentage of SKM-1 cells in G0/G1 phase was decreased and it was increased in S phase.CALR gene played an important role of tumor suppressor gene in the pathogenesis and developing of MDS,whose mutation and loss was a major cause of illness and had important significance for the treatment of MDS of further research of gene sequence.
作者 陈玉 刘凌曦
出处 《基因组学与应用生物学》 CAS CSCD 北大核心 2017年第9期3506-3510,共5页 Genomics and Applied Biology
基金 乐山职业技术学院提供项目资助
关键词 钙网蛋白基因 慢病毒载体 细胞生长 细胞凋亡 骨髓增生异常综合征 CALR(Calreticulin) Lentivirus Cell growth Cell apoptosis MDS(myelodysplastic syndrome)
  • 相关文献

参考文献4

二级参考文献23

  • 1张苏江,李伟达,宋君红,徐卫,仇红霞,李建勇.等位基因特异性聚合酶链反应结合测序对骨髓增殖性疾病JAK2 V617F点突变的研究[J].中华医学杂志,2007,87(30):2109-2112. 被引量:6
  • 2Tefferi A,Lasho TL,Finke C, et al.Typel vs type2 calreticulin mutations in primary myelofibrosis:differences in phenotype and prognostic impact. Leukemia . 2014
  • 3Rampal R,Al-Shahrour F,Abdel-Wahab 0,et al.Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis. Blood . 2014
  • 4Vannucchi AM,Lasho TL,Guglielmelli P,et al.Mutations and prognosis in primary myelofibrosis. Leukemia . 2013
  • 5Aguiar R C,Chase A,Coulthard S,Macdonald D H,Carapeti M,Reiter A,Sohal J,Lennard A,Goldman J M,Cross N C.Abnormalities of chromosome band 8p11 in leukemia: two clinical syndromes can be distinguished on the basis of MOZ involvement. Blood . 1997
  • 6Jones Amy V,Cross Nicholas C P,White Helen E,Green Anthony R,Scott Linda M.Rapid identification of JAK2 exon 12 mutations using high resolution melting analysis. Haematologica . 2008
  • 7Vainchenker William,Delhommeau Fran?ois,Constantinescu Stefan N,Bernard Olivier A.New mutations and pathogenesis of myeloproliferative neoplasms. Blood . 2011
  • 8Kralovics R,Passamonti F,Buser AS,et al.A gain-of-function mutation of JAK2 in myeloproliferative disorders. New England Journal of Medicine, The . 2005
  • 9Tefferi A,Lasho TL,Finke CM, et al.CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis:clinical, cytogenetic and molecular comparisons. Leukemia . 2014
  • 10James C,Ugo V,Le Couedic JP,et al.A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature . 2005

共引文献13

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部